US OptionsDetailed Quotes
HIMS241122C18500
- 6.00
- +1.01+20.24%
15min DelayClose Nov 22 16:00 ET
6.00High5.60Low
5.60Open4.99Pre Close3 Volume31 Open Interest18.50Strike Price1.74KTurnover0.00%IV-3.28%PremiumNov 22, 2024Expiry Date6.83Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.70Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Hims & Hers Health Stock Discussion
Overview
Hims & Hers Health (HIMS) has been a standout performer in 2024, delivering an impressive 194.94% year-to-date return. The company has demonstrated significant growth momentum, driven by strong fundamentals and increasing investor confidence. The recent technical breakout highlights continued upside potential for the stock.
Current Price Analysis
• Current Price (Nov 22, 2024): $25.33
• Daily Change: +$1.18 (+4.89%)
• Post-Mar...
$CrowdStrike (CRWD.US)$ | Stifel analyst Adam Borg maintains CrowdStrike Holdings with a Buy and raises the price target from $300 to $375.
$Alibaba (BABA.US)$ | Barclays analyst Jiong Shao maintains Alibaba with a buy rating, and adjusts the target price from $137 to $130.
$Robinhood (HOOD.US)$ | Bernstein analyst Gautam Chhugani maintain...
Hims & Hers Launches Meal Replacement Bars And Shakes To Enhance Personalized Weight Loss Plans, Offering Comprehensive Nutrition Support For Customers Starting At $110/Month
funds rotating out of tech?
to the moon
Huge buy ?
Is Rivian rivaling Tesla now?
No comment yet